| Title : Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study - Ren_2025_Front.Immunol_16_1692632 |
| Author(s) : Ren L , Chen D , Zhang X , She S , Fei R , Cong X , Mu S , Zhou Y , Gao J , Liao W , Chen H |
| Ref : Front Immunol , 16 :1692632 , 2025 |
| Abstract : |
| PubMedSearch : Ren_2025_Front.Immunol_16_1692632 |
| PubMedID: 41376633 |
| Title : Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study - Ren_2025_Front.Immunol_16_1692632 |
| Author(s) : Ren L , Chen D , Zhang X , She S , Fei R , Cong X , Mu S , Zhou Y , Gao J , Liao W , Chen H |
| Ref : Front Immunol , 16 :1692632 , 2025 |
| Abstract : |
| PubMedSearch : Ren_2025_Front.Immunol_16_1692632 |
| PubMedID: 41376633 |
| Title : Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study - Ren_2025_Front.Immunol_16_1692632 |
| Author(s) : Ren L , Chen D , Zhang X , She S , Fei R , Cong X , Mu S , Zhou Y , Gao J , Liao W , Chen H |
| Ref : Front Immunol , 16 :1692632 , 2025 |
| Abstract : |
| PubMedSearch : Ren_2025_Front.Immunol_16_1692632 |
| PubMedID: 41376633 |